Neutralizing and binding anti-interferon-beta (IFN-beta) antibodies. A comparison between IFN-beta-1a and IFN-beta-1b treatment in multiple sclerosis.
Eur J Neurol. 2000 Jan;7(1):27-34. doi: 10.1046/j.1468-1331.2000.00002.x.
Eur J Neurol. 2000.
PMID: 10809912
Clinical Trial.